Premium
Recent issues in contrast‐induced nephropathy
Author(s) -
Kitajima Kazuhiro,
Maeda Tetsuo,
Watanabe Sanae,
Sugimura Kazuro
Publication year - 2011
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/j.1442-2042.2011.02830.x
Subject(s) - medicine , contrast induced nephropathy , iodinated contrast , nephrotoxicity , nephropathy , complication , contrast (vision) , contrast medium , urology , contrast enhancement , iodinated contrast media , surgery , computed tomography , radiology , kidney , magnetic resonance imaging , endocrinology , diabetes mellitus , artificial intelligence , computer science
Contrast‐induced nephropathy (CIN) is a serious complication resulting from the use of iodinated contrast medium (CM) with potentially high morbidity and mortality. Patients with pre‐existing renal insufficiency appear to be at higher risk of CIN. To prevent CIN among patients undergoing contrast‐enhanced computed tomography, every effort is required, including routine identification of at‐risk patients, the use of appropriate hydration regimens, withdrawal of nephrotoxic drugs, selection of low‐osmolality CM or iso‐osmolar CM, and using the minimum volume of CM possible.